Order Center
 
Product Catalog →  Cell Biology →  Cell Signaling and Neuroscience →  Peptides and Proteins →  Peptides →  Natriuretic Peptides
 Print Preview

Natriuretic Peptides

Description
Biochem/physiol Actions
Product #
Aldosterone Secretion Inhibiting Factor (1-35) ≥97% (HPLC) A natriuretic factor isolated from chromaffin cells that is an agonist at NPR receptors that inhibit aldosterone production. Closely related in structure to brain natriuretic peptide (BNP).
 A7555
Anantin from Streptomyces coerulescens ≥90% (HPLC) Competitive antagonist at atrial natriuretic peptide NPR-A receptors.
 A4316
Atrial Natriuretic Peptide fragment 3-28 rat ≥97% (HPLC) Atrial natriuretic peptide (ANP) is synthesized in myoendocrine cells of the heart from which it is released into the circulation. It exerts natriuretic, diuretic, and vasodilatory effects through stimulation of guanylate cyclase-linked NPR-A receptors. It plays an important role in blood volume and blood pressure homeostasis.
 A6791
Atrial Natriuretic Peptide fragment 4-24 frog ≥97% (HPLC) Atrial natriuretic peptide (ANP) is synthesized in myoendocrine cells of the heart from which it is released into the circulation. It exerts natriuretic, diuretic, and vasodilatory effects through stimulation of guanylate cyclase-linked NPR-A receptors. It plays an important role in blood volume and blood pressure homeostasis.
 A0804
Atrial Natriuretic Peptide fragment 4-28 rat ≥97% (HPLC) Atrial natriuretic peptide (ANP) is synthesized in myoendocrine cells of the heart from which it is released into the circulation. It exerts natriuretic, diuretic, and vasodilatory effects through stimulation of guanylate cyclase-linked NPR-A receptors. It plays an important role in blood volume and blood pressure homeostasis.
 A2677
des(Gln18, Ser19, Gly20, Leu21, Gly22)-Atrial natriuretic peptide fragment 4-23 amide rat ≥95% (HPLC) Atrial natriuretic peptide (ANP) is synthesized in myoendocrine cells of the heart from which it is released into the circulation. It exerts natriuretic, diuretic, and vasodilatory effects through stimulation of guanylate cyclase-linked NPR-A receptors. It plays an important role in blood volume and blood pressure homeostasis.
 A1802
Atrial Natriuretic Peptide human ≥97% (HPLC) Atrial natriuretic peptide (ANP) is synthesized in myoendocrine cells of the heart from which it is released into the circulation. It exerts natriuretic, diuretic, and vasodilatory effects through stimulation of guanylate cyclase-linked NPR-A receptors. It plays an important role in blood volume and blood pressure homeostasis.
 A1663
Atrial Natriuretic Peptide rat ≥97% (HPLC) Atrial natriuretic peptide (ANP) is synthesized in myoendocrine cells of the heart from which it is released into the circulation. It exerts natriuretic, diuretic, and vasodilatory effects through stimulation of guanylate cyclase-linked NPR-A receptors. It plays an important role in blood volume and blood pressure homeostasis.
 A8208
Atriopeptin II rat Activates particulate guanylyl cyclase; cardiac atrial peptide which relaxes both intestinal and vascular smooth muscle.
 A9035
Atriopeptin I rat ≥95% (HPLC) Weak agonist at the cGMP-coupled ANF receptor; cardiac atrial peptide which selectively relaxes intestinal but not vascular smooth muscle.
 A9160
Brain natriuretic peptide fragment 7-32 ≥97% (HPLC) B0777
Brain Natriuretic Peptide-32 human ≥97% (HPLC), powder Brain natriuretic peptide (type B natriuretic peptide) was originally isolated from brain, but is mainly produced in myoendocrine cells of the heart ventricles from which it is released into the circulation. It is involved in blood pressure control and cardiovascular homeostasis.
 B5900
Brain Natriuretic Peptide-32 rat ≥97% (HPLC), powder Brain natriuretic peptide (type B natriuretic peptide) was originally isolated from brain, but is mainly produced in myoendocrine cells of the heart ventricles from which it is released into the circulation. It is involved in blood pressure control and cardiovascular homeostasis.
 B9901
Dendroaspis Natriuretic Peptide trifluoroacetate salt ≥90% (HPLC) Structural homolog of natiuretic peptides containing a 17 amino acid disulfide ring similar to ANP, BNP, and CNP that mediate their physiological effects through particulate guanylyl cyclase receptors generating cGMP.
 D6189
des(Arg30, Pro31)-Dendroaspis Natriuretic Peptide >95% (HPLC), solid N8279
Natriuretic Peptide, C-Type ≥95% (HPLC) C-type natriuretic peptide is produced in the hypothalamus, anterior pituitary, and most major endocrine glands. It has potent venodilatory and coronary vasodilatory effects, but minimal effects on renal function.
 N8768
Pancreatic Polypeptide Fragment 1-17–[Ala31, α-Aminoisobutyryl32]-Neuropeptide Y Fragment 18-36 ≥95% (HPLC), solid Selective agonist of the neuropeptide Y receptor.
 P4488
Pancreastatin Fragment 37-52 human ≥97% (HPLC) P9809
Pancreatic Polypeptide bovine ≥95% (HPLC), powder Agonist at Y4 neuropeptide Y receptors.
 P9778
Pancreatic Polypeptide human ≥95% (HPLC) Agonist at Y4 neuropeptide Y receptors.
 P9903
Pancreatic Polypeptide Rana tempraria >97% (HPLC), solid P4363
Pancreatic Polypeptide rat ≥95% (HPLC) Agonist at Y4 neuropeptide Y receptors.
 P6410
Urodilatin human ≥97% (HPLC) Urodilatin is a natriuretic factor that is produced in the kidney and secreted into the urine. It regulates water and sodium reabsorption in the collecting duct.
 U5754

 Site Use Terms | Terms and Conditions of Sale | Privacy |
Copyrights © 2008 Sigma-Aldrich Co. All Rights Reserved. Reproduction of any materials from the site is strictly forbidden without permission. Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc.